JYOTI KARKI: Open Payments
NPI 1073206371 · CORDELE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 54 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $333 · 2025 $1,295
Food & beverage: $1,115Education: $180
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $189 |
| Regeneron Healthcare Solutions, Inc. | 5 | $146 |
| Grifols USA, LLC | 4 | $131 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $98 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| GENZYME CORPORATION | 3 | $87 |
| Verona Pharma, Inc. | 3 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Prolastin-C Liquid, OFEV, Ohtuvayre, GLASSIA, WINREVAIR, Arikayce.
Industry payments across GA — which companies pay providers there.
